These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 35091195)
1. Metabolic characteristics of [ Kong Z; Li Z; Chen J; Liu S; Liu D; Li J; Li N; Ma W; Feng F; Wang Y; Yang Z; Liu Z Nucl Med Biol; 2022; 106-107():80-87. PubMed ID: 35091195 [TBL] [Abstract][Full Text] [Related]
2. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy. Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447 [TBL] [Abstract][Full Text] [Related]
3. Li Z; Kong Z; Chen J; Li J; Li N; Yang Z; Wang Y; Liu Z Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3113-3121. PubMed ID: 33590273 [TBL] [Abstract][Full Text] [Related]
4. Larger Kong Z; Li Z; Chen J; Ma W; Wang Y; Yang Z; Liu Z EJNMMI Res; 2022 Apr; 12(1):22. PubMed ID: 35435593 [TBL] [Abstract][Full Text] [Related]
5. Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [ Beshr R; Isohashi K; Watabe T; Naka S; Horitsugi G; Romanov V; Kato H; Miyatake SI; Shimosegawa E; Hatazawa J Ann Nucl Med; 2018 Dec; 32(10):702-708. PubMed ID: 30194665 [TBL] [Abstract][Full Text] [Related]
7. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
8. Repeatability of Lodge MA; Holdhoff M; Leal JP; Bag AK; Nabors LB; Mintz A; Lesser GJ; Mankoff DA; Desai AS; Mountz JM; Lieberman FS; Fisher JD; Desideri S; Ye X; Grossman SA; Schiff D; Wahl RL J Nucl Med; 2017 Mar; 58(3):393-398. PubMed ID: 27688473 [TBL] [Abstract][Full Text] [Related]
9. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma. Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921 [TBL] [Abstract][Full Text] [Related]
10. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis. Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322 [TBL] [Abstract][Full Text] [Related]
11. Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma. Kong Z; Jiang C; Liu D; Chen W; Ma W; Cheng X; Wang Y Clin Nucl Med; 2021 Feb; 46(2):103-110. PubMed ID: 33208625 [TBL] [Abstract][Full Text] [Related]
12. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy. Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067 [TBL] [Abstract][Full Text] [Related]
13. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
16. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930 [TBL] [Abstract][Full Text] [Related]
17. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
19. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas. Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001 [TBL] [Abstract][Full Text] [Related]